Bausch Historical Financial Ratios
| BHC Stock | CAD 10.71 0.07 0.66% |
Bausch Health is presently reporting on over 97 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0522, Days Sales Outstanding of 95.54 or Free Cash Flow Yield of 0.27 will help investors to properly organize and evaluate Bausch Health Companies financial condition quickly.
Bausch |
About Bausch Financial Ratios Analysis
Bausch Health CompaniesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Bausch Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Bausch financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Bausch Health history.
Bausch Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Bausch Health Companies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Bausch Health sales, a figure that is much harder to manipulate than other Bausch Health Companies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Bausch Health Companies dividend as a percentage of Bausch Health stock price. Bausch Health Companies dividend yield is a measure of Bausch Health stock productivity, which can be interpreted as interest rate earned on an Bausch Health investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from Bausch Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Bausch Health's Research And Ddevelopement To Revenue is very stable compared to the past year. As of the 22nd of December 2024, Days Payables Outstanding is likely to grow to 147.77, while Price To Sales Ratio is likely to drop 0.32.
| 2023 | 2024 (projected) | Dividend Yield | 0.0579 | 0.0522 | Price To Sales Ratio | 0.33 | 0.32 |
Bausch Health fundamentals Correlations
Click cells to compare fundamentals
Bausch Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bausch Health fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 1.22 | 0.92 | 1.17 | 0.28 | 0.33 | 0.32 | |
| Ptb Ratio | 9.91 | 13.8 | (93.48) | (3.29) | (2.86) | (2.72) | |
| Days Sales Outstanding | 78.04 | 71.71 | 76.82 | 80.42 | 83.28 | 95.54 | |
| Book Value Per Share | 3.23 | 1.7 | (0.0947) | 0.72 | (0.22) | (0.21) | |
| Free Cash Flow Yield | 0.27 | 0.2 | 0.12 | 0.11 | (0.44) | 0.26 | |
| Operating Cash Flow Per Share | 4.26 | 3.13 | 3.97 | (2.01) | 2.83 | 1.9 | |
| Stock Based Compensation To Revenue | 0.0119 | 0.0131 | 0.0152 | 0.0155 | 0.0151 | 0.0209 | |
| Capex To Depreciation | 0.0834 | 0.13 | 0.17 | 0.19 | 0.22 | 0.2 | |
| Pb Ratio | 9.91 | 13.8 | (93.48) | (3.29) | (2.86) | (2.72) | |
| Ev To Sales | 3.86 | 3.83 | 3.79 | 2.77 | 2.78 | 2.64 | |
| Free Cash Flow Per Share | 3.47 | 2.26 | 3.18 | (2.75) | 2.08 | 1.44 | |
| Roic | (0.002628) | 0.0165 | 0.0491 | 0.11 | 0.0706 | 0.0966 | |
| Inventory Turnover | 2.12 | 2.06 | 2.41 | 2.17 | 1.66 | 2.83 | |
| Net Income Per Share | (5.06) | (1.57) | (2.61) | (0.59) | (1.62) | (1.54) | |
| Days Of Inventory On Hand | 171.94 | 177.55 | 151.4 | 168.3 | 220.23 | 128.82 | |
| Payables Turnover | 4.67 | 6.67 | 5.88 | 4.54 | 3.56 | 3.37 | |
| Research And Ddevelopement To Revenue | 0.0548 | 0.0563 | 0.0551 | 0.0651 | 0.069 | 0.0975 | |
| Pocfratio | 7.02 | 6.65 | 6.95 | (3.12) | 2.84 | 2.69 | |
| Interest Coverage | (0.0453) | 0.44 | 0.85 | 0.94 | 0.73 | 0.69 | |
| Capex To Operating Cash Flow | 0.15 | 0.16 | 0.19 | 0.2 | (0.37) | 0.26 | |
| Pfcf Ratio | 8.61 | 9.21 | 8.67 | (2.28) | 3.85 | 3.66 | |
| Days Payables Outstanding | 78.13 | 54.69 | 62.05 | 80.44 | 102.55 | 147.77 | |
| Income Quality | (0.84) | (1.99) | (1.52) | 3.43 | (1.69) | (1.6) | |
| Roe | (1.68) | (1.04) | 8.84 | 0.31 | 0.58 | 0.61 | |
| Ev To Operating Cash Flow | 22.11 | 27.64 | 22.43 | (30.87) | 23.61 | 23.44 | |
| Pe Ratio | (5.91) | (13.21) | (10.58) | (10.72) | (4.94) | (4.7) | |
| Return On Tangible Assets | (0.17) | (0.0576) | (0.0956) | (0.0254) | (0.061) | (0.0579) | |
| Ev To Free Cash Flow | 27.14 | 38.28 | 27.98 | (22.57) | 32.06 | 46.86 | |
| Earnings Yield | (0.17) | (0.0757) | (0.0946) | (0.0933) | (0.2) | (0.19) | |
| Net Debt To E B I T D A | 11.97 | 9.13 | 11.4 | 7.71 | 9.56 | 6.76 | |
| Current Ratio | 0.19 | 1.12 | 1.09 | 1.08 | 1.3 | 1.99 | |
| Tangible Book Value Per Share | (63.02) | (58.83) | (54.16) | (47.2) | (48.56) | (50.99) | |
| Receivables Turnover | 4.68 | 5.09 | 4.75 | 4.54 | 4.38 | 3.69 |
Pair Trading with Bausch Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.Moving against Bausch Stock
| 0.46 | BRY | Bri Chem Corp | PairCorr |
| 0.43 | AAPL | Apple Inc CDR | PairCorr |
| 0.33 | SEC | Senvest Capital | PairCorr |
| 0.31 | NPTH | NeuPath Health | PairCorr |
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.